Literature DB >> 23101424

Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system.

Paulo R Criado1, João Avancini, Claudia G Santi, Ana T Amoedo Medrado, Carlos E Rodrigues, Jozélio F de Carvalho.   

Abstract

The DRESS syndrome (drug reaction with eosinophilia and systemic symptoms), also known as DIHS (drug-induced hypersensitivity syndrome), presents clinically as an extensive mucocutaneous rash, accompanied by fever, lymphadenopathy, hepatitis, hematologic abnormalities with eosinophilia and atypical lymphocytes, and may involve other organs with eosinophilic infiltration, producing damage in several systems, especially kidney, heart, lungs, and pancreas. The pathogenesis is related to specific drugs (especially the aromatic anticonvulsants), altered immune response, sequential reactivation of herpes virus, and association with some HLA alleles. Glucocorticoids are the basis for the treatment of the syndrome, which may be given with intravenous immunoglobulin and, in selected cases, ganciclovir. This article reviews current concepts regarding the interaction of drugs, viruses and immune responses during this complex adverse-drug reaction.

Entities:  

Mesh:

Year:  2012        PMID: 23101424

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  15 in total

1.  Drug Reaction, Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to allopurinol with early lymphadenopathy and symptom relapse.

Authors:  Rhiannon Turney; Jordan Peter Skittrall; Joseph Donovan; Daniel Agranoff
Journal:  BMJ Case Rep       Date:  2015-10-05

2.  Drug rash with eosinophilia and systemic symptoms (DRESS) caused by phenytoin.

Authors:  Muhammad Riaz; Bruce D Ragsdale; Zia Ur Rahman; Gaurav Nigam
Journal:  BMJ Case Rep       Date:  2017-08-22

3.  Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antituberculosis drugs and associated with human herpes virus-7 (HHV-7).

Authors:  Nehal Draz; Sumona Datta; Daniel P Webster; Ian Cropley
Journal:  BMJ Case Rep       Date:  2013-07-31

4.  Two cases with HSS/DRESS syndrome developing after prosthetic joint surgery: does vancomycin-laden bone cement play a role in this syndrome?

Authors:  Müberra Devrim Güner; Semra Tuncbilek; Burak Akan; Aysun Caliskan-Kartal
Journal:  BMJ Case Rep       Date:  2015-05-28

5.  DRESS syndrome potentially induced by allopurinol and triggered by influenza vaccine.

Authors:  Berna Solak; Bahar Sevimli Dikicier; Rabia Oztas Kara; Teoman Erdem
Journal:  BMJ Case Rep       Date:  2016-03-30

Review 6.  Hypereosinophilic Syndrome.

Authors:  Casey Curtis; Princess Ogbogu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

Review 7.  [Differential diagnosis of hypereosinophilia].

Authors:  J C Henes; S Wirths; B Hellmich
Journal:  Z Rheumatol       Date:  2019-05       Impact factor: 1.530

8.  Association of CD8(+) T lymphocyte repertoire spreading with the severity of DRESS syndrome.

Authors:  Jun Niu; Qingzhu Jia; Qingshan Ni; Yi Yang; Gang Chen; Xichuan Yang; Zhifang Zhai; Haili Yu; Peng Guan; Regina Lin; Zhiqiang Song; Qi-Jing Li; Fei Hao; Hua Zhong; Ying Wan
Journal:  Sci Rep       Date:  2015-04-23       Impact factor: 4.379

9.  DRESS syndrome as a complication of treatment of hepatitis C virus-associated post-inflammatory liver cirrhosis with peginterferon α2a and ribavirin.

Authors:  Justyna Janocha-Litwin; Monika Pazgan-Simon; Krzysztof Simon
Journal:  Postepy Dermatol Alergol       Date:  2014-12-03       Impact factor: 1.837

10.  Severe cutaneous adverse drug reactions: a clinicoepidemiological study.

Authors:  Sarita Sasidharanpillai; Najeeba Riyaz; Anza Khader; Uma Rajan; Manikoth P Binitha; Deepthi N Sureshan
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.